Opiant develops medicines to treat addiction disorders and drug overdose
Opiant is a specialty pharmaceutical company developing medicines for addiction and drug overdose. We conceived and developed the first FDA-approved, user-friendly nasal naloxone spray to reverse an opioid overdose. This product, NARCAN® Nasal Spray (“NARCAN®”), became available in the United States and Canada in 2015 through our commercial partner, Adapt Pharma (now a part of Emergent BioSolutions).
The Company’s current pipeline includes medicines in development for Opioid Overdose Reversal (“OOR”), Alcohol Use Disorder (“AUD”), Opioid Use Disorder (“OUD”), and Acute Cannabinoid Overdose (“ACO”). The Company is also pursuing other treatment opportunities within the addiction and drug overdose field.